Cannabidiol found effective in childhood-onset resistant epilepsy Anjali Nimesh Nimesh30 Dec 2017 7:28 PM ISTGW Pharmaceuticals plc (Nasdaq: GWPH, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel...
A highly effective drug approved for Hepatitis C Anjali Nimesh Nimesh2 Jan 2018 7:25 PM ISTHepatitis C is a viral disease which causes inflammation of the liver and ultimately leads to the failure of the liver. According to WHO, 71 million...
Food preservative sodium benzoate is new option for resistant schizophrenia Anjali Nimesh Nimesh2 Feb 2018 7:00 PM ISTIn a randomized, double-blind, placebo-controlled trial conducted by Dr.Hsien-Yuan Lane and associates, it has been concluded that a common food...
Perampanel may reverse protein linked to schizophrenia Anjali Nimesh Nimesh26 Feb 2018 7:28 PM ISTDr.Valina Dawson, Ph.D., professor of neurology in the Johns Hopkins University School of Medicine's Institute have identified rare genetic...
Women with schizophrenia at higher risk of breast cancer - JAMA Anjali Nimesh Nimesh10 March 2018 7:05 PM ISTPatients with schizophrenia are considered to have many risk factors for the development of cancer.But there is uncertainty about the incidence of...
New drug reduces hot flushes & improves sleep quality after menopause Anjali Nimesh Nimesh15 March 2018 7:25 PM ISTMenopause is the process through which a woman ceases to be fertile or menstruate and is associated with night sweats, hot flashes, mood fluctuations,...
Antioxidants and amino acids reduce the symptoms of psychosis Anjali Nimesh Nimesh25 March 2018 7:20 PM ISTDr. Firth, at NICM Health Research Institute, Western Sydney University, and colleagues examined if nutrient supplementation could provide effective...
New PET imaging agent to guide therapy in neurological diseases Anjali Nimesh Nimesh4 April 2018 7:20 PM ISTSwiss and German researchers have developed a new imaging agent that helps and assesses treatments for people with various neurological diseases like...
Valbenazine declared safe for managing tardive dyskinesia Anjali Nimesh Nimesh1 May 2018 7:25 PM ISTFDA had approved Valbenazine (commercial name: Ingrezza) as the first drug for the treatment of tardive dyskinesia in 2017 which is a disorder in...
Single dose injectable antipsychotic approved for initiating schizophrenia treatment Medha Baranwal Baranwal3 July 2018 7:25 PM ISTThe U.S. Food and Drug Administration (FDA) has approved Alkermes's Aristada Initio (aripiprazole lauroxil) for the initiation of Aristada, a...
Prenatal Folic acid fortification prevents mental illness later: JAMA Study Medha Baranwal Baranwal5 July 2018 7:25 PM ISTA new study published in the JAMA Psychiatry shows that prenatal exposure to fortifying grain-based foods with folic acid is associated with...
Rare Case of a Psychiatric patient presenting with Chilaiditi's syndrome Hina Zahid16 July 2018 6:00 PM ISTDr.Vasileiadis P and colleagues have presented a Case of a Psychiatric patient presenting with Chilaiditi's syndrome that has appeared in Clinical...
